VAX Vantex Resources Ltd

The management of Vantex Resources Ltd. (TSX
VENTURE:VAX)(FRANKFURT:UD7A)(ALPHA:VAX) is pleased to announce the appointment
of MM. Jean-Pierre Colin and Andre Brosseau to the Company's Board of Directors.
Mr. Colin will also act as Vantex new President and will be based in Toronto. 


"We are very excited that Jean-Pierre Colin and Andre Brosseau have chosen to
join Vantex. Their combined expertise in investment banking and the mining
industry will be a valuable asset for Vantex shareholders," said Mr. Guy
Morissette, CEO of Vantex.


From 1980 to 2010, Mr. Colin was an investment banker responsible for corporate
finance and M&A and, as such, has advised and helped to finance many Canadian
mining exploration and production companies and has helped to advance numerous
mines into production.


Mr. Colin was formerly Director and Head of Corporate Finance at Octagon Capital
Corporation, an investment banker with Desjardins Securities Inc., Executive
Vice-President of Deacon Capital Corporation, and Senior Vice President of
Richardson Greenshields of Canada Limited.


Mr. Colin was the founder of JP Colin Securities Inc., a securities dealer
providing corporate finance services to numerous junior public mining companies.
He is the former Faculty of Arts Co-Chair of the Waterloo Advisory Council of
the University of Waterloo, founder and President of Caratax Management Ltd., a
manager of public flow-through share limited partnerships, and a founder and
director of NIM Management Ltd.


Mr. Colin is also a director of Premier Gold Mines Ltd., Valterra Resource
Corp., Southern Silver Exploration Corp. and Global Cobalt Corp. (Puget
Ventures). Mr. Colin is a Member of the Bar of the Province of Quebec and holds
a Master of Business Administration from the University of Western Ontario, a
Civil Law Degree from the University of Ottawa and a Certificate in Comparative
Law from the University of Manitoba.


Mr. Brosseau is CEO and COO of Avenue Capital Markets Inc., an exempt market
dealer founded in 2010 with offices in Montreal and New-York. He is also a
Director of Midas Medici Inc., a holding company specializing in acquiring and
merging IT related companies with operations in New York, North Carolina, Europe
and Brazil. He's on the Board of CIMCORP, wholly owned by Midas Medici, an IT
company based in Sao Paulo Brazil. Mr. Brosseau is a Director of Aptilon Inc., a
web based business solution company specializing in the US healthcare sector and
he is also a director of Odesia Inc.. He also serves as the Co-Chair of The
Company Theatre, a not-for-profit organization located in Toronto and member of
the steering committee of Notman House. Mr. Brosseau holds a Bachelor's Degree
(BA) in Science (Political and Economics) and a Master's Degree in Science
(Political Science) from the Universite de Montreal.


Mr. Brosseau was President of Blackmont Capital in Toronto until June 2009 and
Chairman Quebec Capital Markets until May 2010. For 12 years Mr. Brosseau was
with CIBC in different capacities mostly based in Toronto, most recently as
Managing Director, Head of Cash Equities and Co-Head of Global Cash Equities at
CIBC World Markets where he was involved in some of the most important capital
market transactions in Canada. 


Mr. Brosseau will head Vantex audit and compensation committees.

Following their appointment, Mr. Colin received 1,000,000 stock options and Mr.
Brosseau 500,000 stock options. These options are priced at $0.10 and are valid
for a period of 5 years. This grant is subject to the approval of Vantex
increased stock option plan, by arm's length shareholders at the next Annual
Meeting of Shareholders. None of these options will be exercisable until such
approval is obtained.


The Company also announces the resignation of MM. Gilles Laverdiere and Richard
David from the Board of Directors. The Company would like to thank MM.
Laverdiere and David for their contribution to the Board. The Company wishes
them success in their future endeavours.

Vantex Resources (TSXV:VAX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Vantex Resources (TSXV:VAX)
Historical Stock Chart
From Jan 2024 to Jan 2025